ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Companies

Japan's Toray seeks fast approval for 'single drop' cancer blood test

Simple screenings hold promise of helping early detection in tough cases

A woman takes a blood test at a Tokyo convenience store. Japanese materials group Toray has developed a screening for cancer that it says requires little blood.

TOKYO -- Japan materials group Toray Industries will apply this year for fast-track government approval to sell a cancer screening test that requires only one drop of blood.

The method can screen for multiple types of cancer at once and has a precision rate of more than 95%, according to Toray, holding to the potential to contribute to early detection of hard-to-diagnose forms of the disease, such as pancreatic cancer.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more